Fresenius Medical Care AG & Co. KGaA

FMS NYSE Healthcare & Biotech Monde US3580291066
22.03 $
0.46 %

Fresenius Medical Care is a global provider of dialysis products and services for patients with chronic kidney failure.

Price history of Fresenius Medical Care AG & Co. KGaA
Price history of Fresenius Medical Care AG & Co. KGaA

Performance & Momentum

6 Months 1.70 %
1 Year 20.22 %
3 Years 10.38 %
5 Years 38.82 %

Strategic Analysis

Fresenius Medical Care AG & Co. KGaA • 2026

Fresenius Medical Care holds a global leadership position in a vital niche market: renal care and dialysis, combining equipment, consumables, and treatment services. Its business model is built on recurring, defensive activity driven by chronic and structural medical needs, which gives it greater visibility than many healthcare players.

Strengths
  • Dominant position in an essential, non-cyclical medical need
  • Recurring business thanks to the combination of dialysis services and related products
  • Global presence and technical expertise that are difficult to replicate
Weaknesses
  • Exposure to a sector highly subject to reimbursement constraints and margin pressure
  • A long share-price track record that is still under pressure, reflecting a market that remains cautious about execution quality
Momentum

The momentum appears decent but not overly strong, with recent performance still somewhat hesitant despite a more constructive longer-term history. For investors, this points to a turnaround profile rather than an aggressive growth story: the stock could become attractive again if operational discipline and margin improvement are confirmed, but the market is not yet giving the shares clear support.

Similar stocks to Fresenius Medical Care AG & Co. KGaA

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone